Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Stage IV
Colorectal Cancer Market to See Booming Growth 2025-2032 | F Hoffmann-La Roche/Genentech, Amgen Inc
The latest report from Coherent Market Insights examines the growth prospects of the Colorectal Cancer Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth factors, and regional forecasts. The report provides a comprehensive overview by integrating research findings, market assessments, and data from various sources.
Wilms Tumor Global Market Report 2025
Wilms tumor, also known as nephroblastoma, is a form of kidney cancer that primarily affects children, most commonly under the age of 5. The tumor originates in the kidneys, which are responsible for filtering waste from the blood and producing urine. Wilms tumor is marked by the abnormal growth of kidney cells and can present with symptoms such as an abdominal mass, pain, fever, hematuria (blood in the urine), and elevated blood pressure.
Key Appendiceal Cancer Treatment Market Advancements Highlighted by Trend 2025-2034: The Role of Digital Health and Pediatric Oncology Initiative
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! What Is The Market Size And Growth Rate Of The Appendiceal Cancer Treatment Market? The market size for appendiceal cancer treatment has been showing significant growth in the past few years. The market is projected to expand from $3.98 billion in 2024 to $4.21 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%.
Gall Bladder Cancer Treatment Market Advancements Highlighted by Report Analysis, Research Studies
Bladder Cancer Treatment Market Expected to reach a high CAGR 5.5% By 2031 DataM Intelligence has published a new research report on “Gall Bladder Cancer Treatment Market Size 2024”. The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.
Metastatic Melanoma Therapeutics Global Market Report 2023
“Metastatic Melanoma Therapeutics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on metastatic melanoma therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Metastatic Melanoma Therapeutics Market Generated Opportunities, Future Scope 2023-2030 | Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc.
We are delighted to introduce our latest market research report titled Metastatic Melanoma Therapeutics Market. This comprehensive and insightful report provides an in-depth analysis of the industry and offers valuable insights into its current trends, growth prospects, competitive landscape, and future outlook.
Metastatic Melanoma Therapeutics Market :Growth Factors, Types and Application, Demand and Supply Chain Analysis, Forecast To 2030 | Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc.
Global “Metastatic Melanoma Therapeutics Market” is an exploration report with CMI efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. These bits of knowledge offered in the Metastatic Melanoma Therapeutics Market report would benefit request players to define systems for the future and gain a solid situation in the worldwide market request development.
From Breast Cancer Patient To Advocate: Finding the Strength to Speak for Others
“In everyone’s life, at some time, our inner fire goes out. It is then burst into flame by an encounter with another human being. We should all be thankful for those people who rekindle the inner spirit.” Albert Schweitzer I was diagnosed with triple-negative breast cancer (TNBC) in 2019 during the midst of a nasty divorce. People I had once called “friends” faded away, just as the love from my marriage did. Moreover, Covid-19 hit, bringing an end to socialization as we knew it.
For the Breast of Us Breast Cancer Blogs
Having a safe space to share the good, bad, and ugly about my cancer journey, without judgment, meant the world to me. Like this: Like Loading...
Attack on the Liver War Front: Round One!
Well the day is finally just about here! After a longer than wished for wait over the course of May, tomorrow I go in for my first liver-focused therapy – my first attack on the liver front of the war! At 10:00 AM tomorrow morning I’ll be checking in at the UCSD Hillcrest hospital to treat the right lobe of my liver with “Selective Internal Radiation Therapy (Y90-SIRT)�
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Stage
Contact Stage, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack